Tumors of the Male Genital System

  • Ekkehard Grundmann
  • Winfried Vahlensieck

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 60)

Table of contents

  1. Front Matter
    Pages I-XII
  2. Introduction

    1. E. Grundmann, W. Vahlensieck
      Pages 1-2
  3. Prostate Carcinoma

    1. H. Tulinius
      Pages 3-13
    2. G. T. Mellinger
      Pages 61-72
    3. L. Andersson, F. Edsmyr, G. Jönsson, I. Könyves
      Pages 73-77
    4. G. Sesia, U. Ferrando, G. Fontana, M. Laudi, F. Cauda
      Pages 84-90
  4. Penis Carcinoma

    1. L. Persky
      Pages 97-109
    2. P. Lichtenauer, H. Scheer, T. Louton
      Pages 110-119
    3. M. Raynal, D. Chassagne, F. Baillet, B. Pierquin
      Pages 135-139
    4. T. Ichikawa
      Pages 140-156
  5. Carcinoma of the Seminal Vesicles

  6. Epididymal Tumors

    1. E. Elsässer
      Pages 163-175
  7. Testicular Tumors

  8. Back Matter
    Pages 259-270

About this book


E. GRUNDMANN, and W. VAHLENSIECK In recent years tumors of the male genital system have acquired a new scientific importance in many respects: First, epidemiologic studies have revealed a striking increase of prostate carcinoma in northwestern Europe and in the USA; it is now counted among the most frequent malig­ nant tumors in males. Geographic and ethnic distributions suggest that this tumor, too, may be triggered by exogenous factors of a still unknown nature. Histologic classification of malignant tumors of the prostate and testes has attained a certain finality, and the clinical relevance of the stages is recognized. Diagnosis by histology is now supplemented by aspiration biopsy cytology which offers a ready and reliable diagnostic potential. Its safety even surpasses that of punch biopsy histology and supports the qualification of cytology as a screening method. In the Federal Republic of Germany prostate carcinoma was recently included in the cancer prophylaxis program of the social insurance sys­ tem: Every man over 45 is entitled to one prophylactic free examination per year. Although the number of patients profiting from this opportu­ nity is still rather small, the number of patients is steadily growing who, as a result of this prophylactic examination, received medical treatment at an early stage of the disease and with a relatively better prognosis1 . Topical problems of social medicine are discussed in this context, as well as plans and developments of the social health service and of the supporting organizations, the federal societies for cancer campaign.


Tumors biopsy carcinoma classification diagnosis

Editors and affiliations

  • Ekkehard Grundmann
    • 1
  • Winfried Vahlensieck
    • 2
  1. 1.Pathologisches InstitutMünsterDeutschland
  2. 2.Urologische Univ.-KlinikBonn-VenusbergDeutschland

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1977
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-81097-8
  • Online ISBN 978-3-642-81095-4
  • Series Print ISSN 0080-0015
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology